PacificHealth Laboratories, Inc.
PHLI
OTC PK
| 09/30/2012 | 06/30/2012 | ||||
|---|---|---|---|---|---|
| Revenue | -22.79% | 27.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.79% | 27.32% | |||
| Cost of Revenue | -16.66% | 35.39% | |||
| Gross Profit | -32.44% | 16.38% | |||
| SG&A Expenses | -0.74% | 19.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.28% | 28.45% | |||
| Operating Income | -415.09% | -84.79% | |||
| Income Before Tax | -395.55% | -75.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -395.55% | -75.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -395.55% | -75.13% | |||
| EBIT | -415.09% | -84.79% | |||
| EBITDA | -633.64% | -69.17% | |||
| EPS Basic | -403.03% | -73.68% | |||
| Normalized Basic EPS | -390.48% | -75.00% | |||
| EPS Diluted | -506.06% | -73.68% | |||
| Normalized Diluted EPS | -390.48% | -75.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
